Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of FS Grifols for Hemostasis in Parenchymous Tissue Open Surgeries
2013-005128-40Phase 3Completed
- Sponsor
- Grifols
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of VISTASEAL in postoperative hemorrhage (2 arms), sponsored by Grifols. Primary endpoint: Proportion of subjects achieving hemostasis at the target bleeding site by 4 minutes. Started Feb 2014; status: completed.
02
Drugs
VISTASEAL
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on 2013-005128-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005128-40.